Samuel Whittle
Adelaide Medical School
Faculty of Health and Medical Sciences
-
Journals
Year Citation 2025 Saadat, P., Bansback, N., Falahee, M., Hiligsmann, M., Tugwell, P., Buchbinder, R., . . . Hazlewood, G. (2025). Patient preferences for drug therapy in inflammatory arthritis: protocol for a living systematic review and evidence map to inform clinical practice guidelines. BMJ Open, 15(1), 7 pages.
2025 Synnot, A., Chakraborty, S., Xue, J., Cheng, H. Z., Berkovic, D., Turner, T., . . . Glennon, V. (2025). Exploring the use and usefulness of living guidelines for consumers: international online survey of patients' and carers' views. Journal of Clinical Epidemiology, 180, 111671.
Scopus12025 Whittle, S. L., Johnston, R. V., McDonald, S., Worthley, D., Campbell, T. M., Cyril, S., . . . Buchbinder, R. (2025). Stem cell injections for osteoarthritis of the knee.. The Cochrane database of systematic reviews, 4(4), CD013342.
2025 Yiu, Z. Z. N., McFarlane, E., & Whittle, S. L. (2025). ‘Live long and prosper’: living guidelines for immune-mediated inflammatory diseases. Rheumatology, 64(1), 6-8.
2024 Yiu, Z. Z. N., McFarlane, E., & Whittle, S. L. (2024). ‘Live long and prosper’: living guidelines for immune-mediated inflammatory diseases. British Journal of Dermatology, 191(5), 647-649.
2024 Ramsay, H., Johnston, R. V., Cyril, S., Glennon, V., Grobler, L., Burgess, D. M., . . . Buchbinder, R. (2024). Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with psoriatic arthritis in remission or low disease activity. Cochrane Database of Systematic Reviews, 2024(12), CD015880.
2024 Tan, J., Renton, W. D., Whittle, S. L., Takken, T., Johnston, R. V., Tiller, G., . . . Buchbinder, R. (2024). Methotrexate for juvenile idiopathic arthritis. Cochrane Database of Systematic Reviews, 2024(2), CD003129-1-CD003129-67.
Scopus22024 Mittinty, M. M., Mittinty, M. N., Buchbinder, R., Lassere, M., Chand, V., Whittle, S., . . . Hill, C. (2024). Interpersonal Process of Dyadic Coping in Rheumatoid Arthritis: A Perspective From the Australian Rheumatology Association Database. Journal of Rheumatology, 51(9), 862-869.
Scopus12024 Osorio-Tejada, J., Escriba-Gelonch, M., Vertongen, R., Bogaerts, A., & Hessel, V. (2024). CO<inf>2</inf> conversion to CO via plasma and electrolysis: a techno-economic and energy cost analysis. Energy and Environmental Science, 17(16), 5745-6128.
Scopus102024 Pisaniello, H. L., Lester, S. E., Russell, O., Black, R., Tieu, J., Richards, B., . . . Whittle, S. L. (2024). The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). Annals of the Rheumatic Diseases, 83(10), 1400-1402.
2023 Whittle, S. L., Glennon, V., & Buchbinder, R. (2023). Prioritization of clinical questions for the Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis. International Journal of Rheumatic Diseases, 26(12), 2410-2418.
Scopus4 Europe PMC52023 Kamso, M. M., Pardo, J. P., Whittle, S. L., Buchbinder, R., Wells, G., Glennon, V., . . . Hazlewood, G. S. (2023). Crowd-sourcing and automation facilitated the identification and classification of randomized controlled trials in a living review. Journal of Clinical Epidemiology, 164, 1-8.
Scopus2 Europe PMC32023 Ng, J. Q., Jafarov, T. H., Little, C. B., Wang, T., Ali, A. M., Ma, Y., . . . Mukherjee, S. (2023). Loss of Grem1-lineage chondrogenic progenitor cells causes osteoarthritis. Nature Communications, 14(1), 6909-1-6909-14.
Scopus10 Europe PMC132023 Wang, H., Dewidar, O., Whittle, S. L., Ghogomu, E., Hazlewood, G., Leder, K., . . . Welch, V. (2023). Equity Considerations in COVID-19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases. Arthritis Care and Research, 75(5), 967-974.
2023 Cheyne, S., Fraile Navarro, D., Hill, K., McDonald, S., Tunnicliffe, D., White, H., . . . Turner, T. (2023). Methods for living guidelines: early guidance based on practical experience. Paper 1: Introduction. Journal of Clinical Epidemiology, 155, 84-96.
Scopus26 WoS7 Europe PMC172023 Cheyne, S., Fraile Navarro, D., Buttery, A. K., Chakraborty, S., Crane, O., Hill, K., . . . Turner, T. (2023). Methods for living guidelines: early guidance based on practical experience. Paper 3: selecting and prioritizing questions for living guidelines. Journal of Clinical Epidemiology, 155, 73-83.
Scopus16 WoS4 Europe PMC102023 Synnot, A., Hill, K., Davey, J., English, K., Whittle, S. L., Buchbinder, R., . . . Turner, T. (2023). Methods for living guidelines: Early Guidance based on practical experience. Paper 2: Consumer engagement in living guidelines. Journal of Clinical Epidemiology, 155, 97-107.
Scopus8 WoS5 Europe PMC42023 Ng, J. Q., Jafarov, T. H., Little, C. B., Wang, T., Ali, A., Ma, Y., . . . Mukherjee, S. (2023). Loss of Grem1-articular cartilage progenitor cells causes osteoarthritis.. bioRxiv.
2023 Buchbinder, R., Glennon, V., Johnston, R. V., Brennan, S. E., Fong, C., Edward May, S., . . . Whittle, S. L. (2023). Australian recommendations on perioperative use of disease-modifying anti-rheumatic drugs in people with inflammatory arthritis undergoing elective surgery. Internal Medicine Journal, 53(7), 1248-1255.
Scopus2 Europe PMC22023 Pisaniello, H. L., Lester, S., Russell, O., Black, R., Tieu, J., Richards, B., . . . Hill, C. L. (2023). Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). RMD Open, 9(3), e002962.
Scopus5 Europe PMC22023 Lyon, A., Quinlivan, A., Lester, S., Barrett, C., Whittle, S. L., Rowett, D., . . . Hill, C. L. (2023). Vaccination Rates, Perceptions, and Information Sources Used by People With Inflammatory Arthritis. ACR Open Rheumatology, 5(2), 1-9.
Scopus5 WoS2 Europe PMC32023 Taylor, W. J., Willink, R., O'Connor, D. A., Patel, V., Bourne, A., Harris, I. A., . . . Buchbinder, R. (2023). Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT).. PloS one, 18(3), e0281308.
Scopus2 WoS1 Europe PMC12023 Barrett, C., & Whittle, S. (2023). Philip Cameron Robinson, 1979-2023. Internal medicine journal, 53(3), 309-310.
2023 Sharma, C., Whittle, S., Haghighi, P. D., Burstein, F., & Keen, H. I. (2023). Response to Correspondence on Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis'' by Reuter et al. Annals of the Rheumatic Diseases, 82(4), E92.
2022 Renton, W. D., Tiller, G., Munro, J., Tan, J., Johnston, R. V., Avery, J. C., . . . Buchbinder, R. (2022). Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis. Cochrane Database of Systematic Reviews, 2022(1), 1-17.
Scopus12022 Feterman Jimenez, D., Duron, G., Hendin, J., Mantovani Cardoso, E., Valenzuela-Almada, M. O., Vallejo, S., . . . Putman, M. S. (2022). Industry involvement in rheumatology consensus-based recommendations: a systematic review. The Lancet Rheumatology, 4(2), e145-e152.
2022 Lalor, A. F., Brooker, J. E., Rozbroj, T., Whittle, S. L., Hill, C. L., Rowett, D., . . . O'Connor, D. A. (2022). Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies. Seminars in Arthritis and Rheumatism, 55, 151988-1-151988-13.
Scopus4 WoS2 Europe PMC42022 Lee, C., Thomas, M., Ejaredar., Kassam, A., Whittle, S. L., Buchbinder, R., . . . Hazlewood, G. S. (2022). Crowdsourcing trainees in a living systematic review provided valuable experiential learning opportunities: A mixed-methods study. Journal of Clinical Epidemiology, 147, 142-150.
Scopus6 WoS2 Europe PMC32022 Khoo, T., Hill, C. L., Hoon, E., & Whittle, S. (2022). Patient Perspectives of Disease Activity, Medications and Substance Use in People with Fibromyalgia. Open Access Rheumatology: Research and Reviews, 14, 87-95.
Scopus1 Europe PMC12022 Whittle, S. L., Glennon, V., Johnston, R. V., Avery, J. C., Bell, J. S., Brennan, S. E., . . . Buchbinder, R. (2022). Australian recommendations on tapering of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in inflammatory arthritis. Internal Medicine Journal, 52(10), 1799-1805.
Scopus7 WoS1 Europe PMC52022 Ponkilainen, V., Karjalainen, T. V., Kuitunen, I., Uimonen, M., Johnston, R. V., Saarinen, A., . . . Buchbinder, R. (2022). Perioperative use of disease modifying anti-rheumatic drugs (DMARDs) in people with inflammatory arthritis. Cochrane Database of Systematic Reviews, 2022(5).
2022 Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Rowett, D., Black, R., . . . Hill, C. (2022). Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars. Rheumatology Advances in Practice, 6(3), rkac099-1-rkac099-7.
Scopus5 WoS1 Europe PMC32022 Tsakas, J. J., Liew, D. F. L., Adams, C. L., Hill, C. L., Proudman, S., Whittle, S., . . . Robinson, P. C. (2022). Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees. BMC Rheumatology, 6(1), 59-1-59-8.
2022 Pisaniello, H. L., Whittle, S. L., Lester, S., Menz, F., Metcalf, R., McWilliams, L., . . . Proudman, S. (2022). Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis. BMC Rheumatology, 6(1), 11 pages.
Scopus5 WoS2 Europe PMC72022 Tiller, G., Renton, W. D., Tan, J., Whittle, S., Avery, J., Munro, J., & Buchbinder, R. (2022). Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis.. Pediatric rheumatology online journal, 20(1), 52.
Scopus2 WoS1 Europe PMC22022 Khoo, T., Chin, A., & Whittle, S. (2022). Fibromyalgia: Small steps on a long journey. Medicine Today, 23(1-2), 43-48. 2021 Adams, L., Lester, S., Hoon, E., van der Haak, H., Proudman, C., Hall, C., . . . Hill, C. L. (2021). Patient satisfaction and acceptability with telehealth at specialist medical outpatient clinics during the COVID-19 pandemic in Australia.. Internal medicine journal, 51(7), 1028-1037.
Scopus36 WoS20 Europe PMC302021 Whittle, S. L., Hazlewood, G. S., Robinson, P., Johnston, R. V., Leder, K., Glennon, V., . . . Buchbinder, R. (2021). COVID-19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies. Cochrane Database of Systematic Reviews, 2021(6), 16 pages.
Scopus12021 Glennon, V., Whittle, S. L., Hill, C. L., Johnston, R. V., Avery, J. C., Grobler, L., . . . Buchbinder, R. (2021). Short-term glucocorticoids for flares in people with rheumatoid arthritis receiving disease-modifying anti-rheumatic drugs (DMARDs). Cochrane Database of Systematic Reviews, 2021(11), 16 pages.
Scopus42021 Avery, J. C., Whittle, S. L., Johnston, R. V., Grobler, L., McKenzie, B. J., Cyril, S., . . . Buchbinder, R. (2021). Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity. Cochrane Database of Systematic Reviews, 2021(11), 16 pages.
2021 McKenzie, B. J., Whittle, S. L., Johnston, R. V., Hill, C. L., Pardo Pardo, J., Glennon, V., . . . Buchbinder, R. (2021). Long-term glucocorticoids for rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2021(12), 17 pages.
Scopus2 WoS12021 Venter, G., Tieu, J., Black, R., Lester, S., Leonardo, N., Whittle, S. L., . . . Hill, C. L. (2021). PERSPECTIVES OF GLUCOCORTICOID USE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. ACR Open Rheumatology, 3(4), 231-238.
Scopus13 WoS7 Europe PMC82021 Ferreira, G. E., Zadro, J. R., O'Keeffe, M., Buchbinder, R., Maher, C., Latimer, J., . . . Clavisi, O. (2021). Challenges faced by musculoskeletal health research in Australia and New Zealand due to the COVID-19 pandemic. Internal Medicine Journal, 51(4), 622.
Scopus12021 Davis, C. R., Ruediger, C. D., Dyer, K. A., Lester, S., Graf, S. W., Kroon, F. P. B., . . . Hill, C. L. (2021). Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH). Osteoarthritis and Cartilage, 29(2), 208-214.
Scopus29 WoS11 Europe PMC172021 Khadra, Y., Walker, J. G., Hakendorf, P., Proudman, S., Rischmueller, M., Hill, C. L., . . . Roberts-Thomson, P. J. (2021). Scleroderma renal crisis: observations from the South Australian Scleroderma Register. Internal Medicine Journal, 51(2), 235-242.
Scopus1 WoS12020 Sharma, C., Whittle, S., Haghighi, P. D., Burstein, F., Sa'adon, R., & Keen, H. (2020). Mining Social Media Data to Investigate Patient Perceptions Regarding DMARD Pharmacotherapy for Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 79(11), 1432-1437.
Scopus12 WoS9 Europe PMC92020 Røe, Y., Buchbinder, R., Grotle, M., Whittle, S., Ramiro, S., Huang, H., . . . Østensjø, S. (2020). What do the OMERACT shoulder core set candidate instruments measure? An analysis using the refined international classification of functioning, disability, and health linking rules. Journal of Rheumatology, 47(10), 1557-1564.
Scopus2 WoS3 Europe PMC22020 Hazlewood, G. S., Whittle, S. L., Kamso, M. M., Akl, E. A., Wells, G. A., Tugwell, P., . . . Buchbinder, R. (2020). Disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews, 2020(3).
Scopus172020 Putman, M. S., Sufka, P., Whittle, S., & Robinson, P. C. (2020). European consensus statements for interstitial lung disease in systemic sclerosis. The Lancet Rheumatology, 2(6), e317-e318.
2020 Leonardo, N., Lester, S., Graham, M., Barett, C., Whittle, S., Rowett, D., . . . Hill, C. L. (2020). Selection and perception of methotrexate treatment information in people with rheumatoid arthritis. International Journal of Rheumatic Diseases, 23(6), 805-812.
Scopus20 WoS13 Europe PMC142020 Szeto, C. -C., Sugano, K., Wang, J. -G., Fujimoto, K., Whittle, S., Modi, G. K., . . . Chan, F. K. L. (2020). Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.. Gut, 639(4), 617-629.
Scopus89 WoS49 Europe PMC422020 Buchbinder, R., Bourne, A., Latimer, J., Harris, I., Whittle, S., Richards, B., . . . ANZMUSC Clinical Trial Network. (2020). Early development of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network. Internal medicine journal, 50(1), 17-23.
Scopus9 WoS6 Europe PMC102020 Leonardo, N., Lester, S., Whittle, S., & Rischmueller, M. (2020). Review of gout clinic in a tertiary hospital setting.. Intern Med J, 50(1), 117-120.
Scopus5 WoS4 Europe PMC12020 Lowe, J. R., Briggs, A. M., Whittle, S., & Stephenson, M. D. (2020). A systematic review of the effects of probiotic administration in inflammatory arthritis. Complementary Therapies in Clinical Practice, 40, 101207-1-101207-13.
Scopus22 WoS10 Europe PMC102020 Sharma, C., Whittle, S., Haghighi, P. D., Burstein, F., & Keen, H. (2020). Sentiment analysis of social media posts on pharmacotherapy: A scoping review. Pharmacology Research and Perspectives, 8(5), 9 pages.
Scopus13 WoS4 Europe PMC102020 Buchbinder, R., Ramiro, S., Huang, H., Gagnier, J. J., Jia, Y., & Whittle, S. L. (2020). Measures of Adult Shoulder Function. Arthritis Care and Research, 72(S10), 250-293.
Scopus13 WoS5 Europe PMC112019 Wilsdon, T. D., Whittle, S. L., Thynne, T. R., & Mangoni, A. A. (2019). Methotrexate for psoriatic arthritis. Cochrane Database of Systematic Reviews, 2019(1), 111 pages.
Scopus17 WoS31 Europe PMC282019 Ramiro, S., Page, M. J., Whittle, S. L., Huang, H., Verhagen, A. P., Beaton, D. E., . . . Buchbinder, R. (2019). The OMERACT core domain set for clinical trials of shoulder disorders. The Journal of Rheumatology, 46(8), 969-975.
Scopus33 WoS22 Europe PMC232019 Tam, L. S., Wei, J. C. C., Aggarwal, A., Baek, H. J., Cheung, P. P., Chiowchanwisawakit, P., . . . Lau, C. S. (2019). 2018 APLAR axial spondyloarthritis treatment recommendations. International Journal of Rheumatic Diseases, 22(3), 340-356.
Scopus58 WoS44 Europe PMC332019 Page, M. J., O'Connor, D. A., Malek, M., Haas, R., Beaton, D., Huang, H., . . . OMERACT Shoulder Core Set Working Group. (2019). Patients' experience of shoulder disorders: a systematic review of qualitative studies for the OMERACT Shoulder Core Domain Set. Rheumatology, 58(8), 1410-1421.
Scopus38 WoS27 Europe PMC292019 Ying Chan, F. L., Lester, S., Whittle, S. L., & Hill, C. L. (2019). The utility of ESR, CRP and platelets in the diagnosis of GCA. BMC Rheumatology, 3(1), 7 pages.
Scopus39 WoS26 Europe PMC252019 Whittle, S. L., Johnston, R. V., McDonald, S., Worthley, D., Campbell, T. M., & Buchbinder, R. (2019). Stem cell injections for osteoarthritis of the knee. Cochrane Database of Systematic Reviews, 2019(5).
Scopus72019 Whittle, S. L., Johnston, R. V., McDonald, S., Paterson, K. L., & Buchbinder, R. (2019). Autologous blood product injections including platelet-rich plasma for osteoarthritis of the knee. Cochrane Database of Systematic Reviews, 2019(5).
Scopus52019 Cai, K., Whittle, S. L., Richards, B. L., Ramiro, S., Falzon, L., & Buchbinder, R. (2019). Marine oil supplements for rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2019(12).
Scopus12018 Wilsdon, T., Thynne, T., Mangoni, A., & Whittle, S. (2018). METHOTREXATE FOR PSORIATIC ARTHRITIS. INTERNAL MEDICINE JOURNAL, 48, 14. 2018 Bourne, A. M., Johnston, R. V., Cyril, S., Briggs, A. M., Clavisi, O., Duque, G., . . . Buchbinder, R. (2018). Scoping review of priority setting of research topics for musculoskeletal conditions. BMJ Open, 8(12), e023962-1-e023962-9.
Scopus32 WoS23 Europe PMC222018 Pisaniello, H., Lester, S., Gonzalez-Chica, D., Stocks, N., Longo, M., Sharplin, G., . . . Hill, C. (2018). Gout prevalence and predictors of urate-lowering therapy use: Results from a population-based study. Arthritis Research and Therapy, 20(1), 10 pages.
Scopus39 WoS31 Europe PMC182018 Chua, A. C. L., Venkataraman, K., & Whittle, S. L. (2018). Occipital condyle syndrome mimicking giant cell arteritis as the first manifestation of disseminated malignancy. Internal Medicine Journal, 48(9), 1163-1164.
Scopus2 WoS12018 Lowe, J., Briggs, A., Whittle, S., Hoon, E., & Stephenson, M. (2018). Effectiveness of probiotics in the management of inflammatory arthritis: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Report, 16(12), 2295-2303.
Scopus5 Europe PMC12017 Wilsdon, T. D., Whittle, S. L., Thynne, T. R. J., & Mangoni, A. A. (2017). Methotrexate for psoriatic arthritis. Cochrane Database of Systematic Reviews, 2017(7).
Scopus362017 Black, R., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., March, L., . . . Hill, C. (2017). Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry. Arthritis Research and Therapy, 19(1), 253-1-253-8.
Scopus36 WoS27 Europe PMC222017 Truong, S. L., Saad, N. F., Robinson, P. C., Cowderoy, G., Lim, I., Schachna, L., . . . Brown, M. A. (2017). Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand. Journal of Medical Imaging and Radiation Oncology, 61(1), 58-69.
Scopus9 WoS8 Europe PMC42017 Haghighi, P. D., Kang, Y. B., Buchbinder, R., Burstein, F., & Whittle, S. (2017). Investigating subjective experience and the influence of weather among individuals with fibromyalgia: A content analysis of Twitter. JMIR Public Health and Surveillance, 3(1), e4.
Scopus18 Europe PMC92017 Goldacre, B., Whittle, S., Ernst, E., & Mendel, J. (2017). Authors' reply to Beales. BMJ (Online), 356, 1 page.
2016 Pisaniello, H. L., & Whittle, S. (2016). Fibromyalgia: Finding the silver lining around a common chronic pain disorder. Medicine Today, 17(12), 54-56. 2016 Milman, N., Whittle, S., Hill, C., El Sayad, J., & Wells, G. (2016). Methotrexate for polymyalgia rheumatica. Cochrane Database of Systematic Reviews, 2016(5), 9 pages.
2016 Milman, N., Hill, C., Whittle, S., El Sayad, J., & Wells, G. (2016). Methotrexate for giant cell arteritis. Cochrane Database of Systematic Reviews, 2016(5), 9 pages.
Scopus12016 Tieu, J., Lester, S., Whittle, S., Peh, C. A., Goldblatt, F., Proudman, S., . . . Hill, C. (2016). RITUXIMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS: A REVIEW OF USE IN SOUTH AUSTRALIA. INTERNAL MEDICINE JOURNAL, 46, 35. 2016 Bird, P., Shnier, R., Taylor, A., White, C., Whittle, S., Basic, N., . . . Tesla, P. (2016). EFFECT OF CALIBRATION AND TRAINING ON MAGNETIC RESONANCE IMAGING SACROILIITIS SCORING AND SI JOINT RADIOGRAPHIC SCORING AGREEMENT. INTERNAL MEDICINE JOURNAL, 46, 38. 2016 Mendel, J., Goldacre, B., Ernst, E., & Whittle, S. (2016). Problems with ethical approval and how to fix them: Lessons from three trials in rheumatoid arthritis. BMJ (Online), 354, 1-4.
Scopus7 WoS6 Europe PMC32015 Ting, K., Graf, S. W., & Whittle, S. L. (2015). Update on the diagnosis and management of gout. MEDICAL JOURNAL OF AUSTRALIA, 203(2), 86-+.
WoS32015 Whittle, S., & Buchbinder, R. (2015). Rotator Cuff Disease. ANNALS OF INTERNAL MEDICINE, 162(1), ITC1-ITC16.
WoS422015 Ting, K., Hill, C., & Whittle, S. (2015). Quality of reporting of interventional animal studies in rheumatology: a systematic review using the ARRIVE guidelines. International Journal of Rheumatic Diseases, 18(5), 488-494.
Scopus34 WoS28 Europe PMC222015 Ting, K., Graf, S. W., & Whittle, S. L. (2015). Update on the diagnosis and management of gout. Medical Journal of Australia, 203(2), 86-88.
Scopus5 WoS1 Europe PMC32015 Whittle, S., & Buchbinder, R. (2015). Rotator cuff disease. Annals of Internal Medicine, 162(1), ITC1-ITC15.
Scopus75 WoS1 Europe PMC542015 Graf, S., Whittle, S., Wechalekar, M., Moi, J., Barrett, C., Hill, C., . . . Zochling, J. (2015). Australian and New Zealand recommendations for the diagnosis and management of gout: Integrating systematic literature review and expert opinion in the 3e Initiative. International Journal of Rheumatic Diseases, 18(3), 341-351.
Scopus52 WoS32 Europe PMC302014 Graf, S. W., & Whittle, S. L. (2014). Isotretinoin-induced skeletal hyperostosis. SpringerPlus, 3(1), 698-1-698-4.
Scopus3 WoS2 Europe PMC42014 Moghaddami, M., James, M., Whittle, S., & Cleland, L. (2014). Synovial fluid myeloid dendritic cells display important differences compared to monocyte-derived dendritic cells prepared in vitro. Clinical & Translational Immunology, 3(8), e23-1-e23-7.
Scopus1 WoS12014 Richards, B. L., Whittle, S., Buchbinder, R., Barrett, C., Lynch, N., Major, G., . . . Zochling, J. (2014). Australian and New Zealand evidence-based recommendations for pain management by pharmacotherapy in adult patients with inflammatory arthritis. International Journal of Rheumatic Diseases, 17(7), 738-748.
Scopus3 WoS1 Europe PMC22014 Robinson, P., Bird, P., Lim, I., Saad, N., Schachna, L., Taylor, A., . . . Brown, M. (2014). Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA). International Journal of Rheumatic Diseases, 17(5), 548-556.
Scopus12 WoS10 Europe PMC82014 Bourne, A. M., Whittle, S. L., Richards, B. L., Maher, C. G., & Buchbinder, R. (2014). The scope, funding and publication of musculoskeletal clinical trials performed in Australia. Medical Journal of Australia, 200(2), 88-91.
Scopus20 WoS18 Europe PMC142013 Graf, S., Buchbinder, R., Zochling, J., & Whittle, S. (2013). The accuracy of methods for urate crystal detection in synovial fluid and the effect of sample handling: A systematic review. Clinical Rheumatology, 32(2), 225-232.
Scopus31 WoS23 Europe PMC162013 Whittle, S., Richards, B., & Buchbinder, R. (2013). Opioid analgesics for rheumatoid arthritis pain. JAMA: Journal of the American Medical Association, 309(5), 485-486.
Scopus26 WoS21 Europe PMC172012 Wechalekar, M., Lester, S., Proudman, S., Cleland, L., Whittle, S., Rischmueller, M., & Hill, C. (2012). Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement. Arthritis and Rheumatism, 64(5), 1316-1322.
Scopus49 WoS43 Europe PMC332012 Whittle, S., Colebatch, A., Buchbinder, R., Edwards, C., Adams, K., Englbrecht, M., . . . van der Heijde, D. (2012). Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e initiative. Rheumatology, 51(8), 1416-1425.
Scopus77 WoS49 Europe PMC332012 Whittle, S. L., Richards, B. L., van der Heijde, D. M., & Buchbinder, R. (2012). The efficacy and safety of opioids in inflammatory arthritis: a cochrane systematic review. The Journal of Rheumatology, 39(Suppl. 90), 40-46.
Scopus18 WoS17 Europe PMC162012 Richards, B. L., Whittle, S. L., van der Heijde, D. M., & Buchbinder, R. (2012). The efficacy and safety of muscle relaxants in inflammatory arthritis: a Cochrane systematic review. The Journal of Rheumatology, Suppl. 90(SUPPL. 90), 34-39.
Scopus15 WoS9 Europe PMC72012 Richards, B. L., Whittle, S. L., van der Heijde, D. M., & Buchbinder, R. (2012). The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review. Journal of Rheumatology, 39(90), 21-27.
Scopus21 WoS14 Europe PMC102012 Richards, B. L., Whittle, S. L., van der Heijde, D. M., & Buchbinder, R. (2012). Efficacy and safety of neuromodulators in inflammatory arthritis: a Cochrane systematic review. Journal of Rheumatology, 39(Suppl. 90), 28-33.
Scopus9 WoS7 Europe PMC32012 Richards, B., Whittle, S., & Buchbinder, R. (2012). Neuromodulators for pain management in rheumatoid arthritis. Cochrane Database of Systematic Reviews, 1(1), 1-51.
Scopus78 WoS55 Europe PMC452012 Richards, B., Whittle, S., & Buchbinder, R. (2012). Muscle relaxants for pain management in rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2012(1), CD008922-1-CD008922-38.
Scopus70 WoS22 Europe PMC282012 Leah, E. (2012). Rheumatoid arthritis: Putting feet forward in disease assessment.. Nature reviews. Rheumatology, 8(2), 64.
2011 Richards, B. L., Whittle, S. L., & Buchbinder, R. (2011). Antidepressants for pain management in rheumatoid arthritis. Cochrane Database of Systematic Reviews (Online), 11(11), 1-67.
Scopus58 WoS33 Europe PMC372011 Whittle, S. L., Richards, B. L., Husni, E., & Buchbinder, R. (2011). Opioid therapy for treating rheumatoid arthritis pain. Cochrane database of systematic reviews (Online), (11), 1-60.
Scopus103 WoS77 Europe PMC512010 Katikireddi, V., Whittle, S., & Hill, C. (2010). Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis. International Journal of Rheumatic Diseases, 13(1), 12-26.
Scopus22 WoS19 Europe PMC142010 Wechalekar, M. D., Rischmueller, M., Whittle, S., Burnet, S., & Hill, C. L. (2010). Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab. Journal of Clinical Rheumatology, 16(2), 79-80.
Scopus19 WoS14 Europe PMC122009 Hill, C. L., Cole, A., Lester, S., & Whittle, S. L. (2009). Steroid sparing drug treatments for giant cell arteritis. Cochrane Database of Systematic Reviews, (1).
Scopus22009 Whittle, S. L., Cole, A., Lester, S., & Hill, C. L. (2009). Steroid sparing drug treatments for polymyalgia rheumatica. Cochrane Database of Systematic Reviews, (1).
2008 Mangat, P., Whittle, S., Cleland, L., & Limaye, S. (2008). Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapy. Clinical Rheumatology, 27(12), 1593-1595.
Scopus3 WoS3 Europe PMC22004 Whittle, S. L., & Hughes, R. A. (2004). Folate supplementation and methotrexate treatment in rheumatoid arthritis: A review. Rheumatology, 43(3), 267-271.
Scopus226 WoS167 Europe PMC1272004 Bamji, A., Whittle, S., & Hughes, R. A. (2004). Methotrexate and folic: What is the optimal combination? (multiple letters) [7]. Rheumatology, 43(8), 1060-1061.
Scopus1 Europe PMC12004 Whittle, S., & Hughes, R. A. (2004). Methotrexate and folic acid: what is the optimal combination? Reply. RHEUMATOLOGY, 43(8), 1061.
2002 Whittle, S., James, M., & Cleland, L. G. (2002). Focus on meloxicam. Medicine Today, 3(9), 73-76. 1996 Edwards, D. J., Whittle, S. L., Nissen, M. J., Cohen, B., Oakeshott, R. D., & Keene, G. C. R. (1996). Radiographic changes in the knee after meniscal transplantation - An experimental study in a sheep model. AMERICAN JOURNAL OF SPORTS MEDICINE, 24(2), 222-226.
WoS28 Europe PMC171988 TILLER, J. W. G., MAGUIRE, K. P., SCHWEITZER, I., BIDDLE, N., CAMPBELL, D. G., OUTCH, K., & DAVIES, B. M. (1988). THE DEXAMETHASONE SUPPRESSION TEST - A STUDY IN A NORMAL POPULATION. PSYCHONEUROENDOCRINOLOGY, 13(5), 377-384.
WoS20 Europe PMC161980 HEYMA, P., LARKINS, R. G., & CAMPBELL, D. G. (1980). INHIBITION BY PROPRANOLOL OF 3,5,3'-TRIIODOTHYRONINE FORMATION FROM THYROXINE IN ISOLATED RAT RENAL TUBULES - AN EFFECT INDEPENDENT OF BETA-ADRENERGIC-BLOCKADE. ENDOCRINOLOGY, 106(5), 1437-1441.
WoS52 Europe PMC27- Mittinty, M. M., Mittinty, M., Buchbinder, R., Lassere, M., Chand, V., Whittle, S., . . . Hill, C. (n.d.). Dyadic Coping with Rheumatoid Arthritis: A Couple Perspective from the Australian Rheumatology Association Database Registry. -
Conference Papers
Year Citation 2024 Terrett, A., Chin, A., Kwon, M., Whittle, S., & Hill, C. (2024). Recommendations for the Perioperative Use of DMARDs in Rheumatic Diseases: A Scoping Review. In ARTHRITIS & RHEUMATOLOGY Vol. 76 (pp. 2123-2124). WILEY. 2024 Hill, C., Kwon, M., Chin, A., Lester, S., & Whittle, S. (2024). DMARD MONITORING IN RHEUMATOID ARTHRITIS: A SCOPING REVIEW OF INTERNATIONAL/NATIONAL GUIDELINES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83 (pp. 2 pages). ELSEVIER.
DOI2023 Crouch, B., Kwiatek, R., True, B., Whittle, S., Wall, A., & Sherwood, V. (2023). DIFFUSION TENSOR IMAGING IN FIBROMYALGIA SYNDROME-A PILOT STUDY. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 32-33). WILEY. 2023 Kwiatek, R., & Whittle, S. (2023). MEMANTINE-A USEFUL BUT FORGOTTEN PAIN MODULATOR IN FIBROMYALGIA MANAGEMENT? A CLINICAL AUDIT. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 33). WILEY. 2023 Schwetlik, S., Wigg, A., Tieu, J., Lyne, S., Whittle, S., Proudman, S., & Hill, C. (2023). THE VALUE OF AN ADVANCED PRACTICE PHYSIOTHERAPIST-LED NEW PATIENT RHEUMATOLOGY SERVICE: A CLINICAL AUDIT OF THE MUSCULOSKELETAL ASSESSMENT CLINIC AT THE QUEEN ELIZABETH HOSPITAL. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 17-18). WILEY. 2023 Sukkar, M., Keen, H., March, L., Proudman, S., Bradbury, L., Hardy, L., . . . Hill, C. (2023). DEVELOPING QUALITY STANDARDS FOR THE DIAGNOSIS AND MANAGEMENT OF RHEUMATOID ARTHRITIS IN AUSTRALIA. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 52). WILEY. 2023 Pisaniello, H. L., Lester, S., Russell, O., Black, R., Tieu, J., Richards, B., . . . Whittle, S. (2023). POORER PAIN-RELATED HEALTH STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS CORRELATES WITH AN INCREASE IN HOSPITALISATIONS AND MORTALITY: A PROSPECTIVE COHORT ANALYSIS USING THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 22). WILEY. 2023 Pisaniello, H. L., Lester, S., Russell, O., Black, R., Tieu, J., Richards, B., . . . Hill, C. (2023). TRAJECTORIES OF SELF-REPORTED PAIN-RELATED HEALTH OUTCOMES AND THE ASSOCIATION WITH SOCIODEMOGRAPHIC FACTORS AND MEDICATION USE IN RHEUMATOID ARTHRITIS: A PROSPECTIVE COHORT ANALYSIS USING THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 21-22). WILEY. 2023 Dartnell, J., Brown, S., Barrett, C., Hardy, L., Buchbinder, R., Whittle, S., . . . Hill, C. (2023). COLLECTIVE IMPACT APPROACH FOR MORE EFFECTIVE KNOWLEDGE TRANSLATION. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 53). WILEY. 2023 Lovato, N., Reynolds, A., Whittle, S., Watson, N., Dyer, K., Gill, T., . . . Hill, C. (2023). DEFINING CLINICAL SLEEP DISORDERS IN FIBROMYALGIA: ROLE FOR UNIVERSAL SCREENING?. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 41). WILEY. 2022 Khoo, T., Lester, S., Hill, C., Whittle, S., Black, R., Tieu, J., & Rischmueller, M. (2022). CONNECTIVE TISSUE DISEASE RELATED INTERSTITIAL LUNG DISEASE IN A RHEUMATOLOGY CLINIC POPULATION. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 35). WILEY. 2022 Russell, O., Khoo, T., Hill, C., Whittle, S., Tieu, J., Lyne, S., & Burnet, S. (2022). AN EXPERIENCE OF THE FIRST PUBLIC RURAL RHEUMATOLOGY CLINIC IN SOUTH AUSTRALIA (SA). In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 35). WILEY. 2022 Ye, M. J., Sinnathurai, P., Hill, C., Barrett, C., Hardy, L., Buchbinder, R., . . . Quyen, D. (2022). ENGAGING CLINICIANS AND CONSUMERS IN THE DESIGN AND IMPLEMENTATION OF A NATIONAL EDUCATION PROGRAM FOR INFLAMMATORY ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 31). WILEY. 2021 Khoo, T., Hill, C., Hoon, E., & Whittle, S. (2021). MEDICATION USE, COMORBIDITIES AND DISEASE ACTIVITY OF PATIENTS WITH FIBROMYALGIA IN A HOSPITAL OUTPATIENT CLINIC. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 48). WILEY. 2021 Lyon, A., Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Marine, F., . . . Hill, C. (2021). VACCINATION RATES, PERCEPTIONS AND INFORMATION SOURCES UTILISED BY AUSTRALIAN PATIENTS WITH INFLAMMATORY ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 15). WILEY. 2021 Sheppard, J., Dartnell, J., Granger, R., Sinnathurai, P., Buchbinder, R., Hill, C., . . . Hayward, K. (2021). INITIATING A NATIONAL CONSORTIUM APPROACH TO SUPPORT OPTIMAL USE OF bDMARDs. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 22-23). WILEY. 2021 Kwiatek, R., Crouch, B., True, B., Whittle, S., Walls, A., & Sherwood, V. (2021). NEUROINFLAMMATION IN PRECUNEUS AND ISOLATED ELEVATED CHOLINE IN MEDIAL PREFRONTAL CORTEX CONFIRMED IN FIBROMYALGIA SYNDROME. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 43-44). WILEY. 2021 Johnson, J., Lynch, L., Gordon, M., Whittle, S., & Hill, C. (2021). EXPLORING OPIOID USE IN THE CONTEXT OF RHEUMATOLOGY DISEASE IN AN OUTPATIENT SETTING. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 24-25). WILEY. 2021 Danicic, J., Jung, M., Stamp, L., Dalbeth, N., & Whittle, S. (2021). STEM CELL THERAPY FOR MUSCULOSKELETAL DISEASES: A RAPID REVIEW. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 35). WILEY. 2021 Lian, A., Keen, H., Whittle, S., & Sharma, C. (2021). A COMPARISON BETWEEN RHEUMATOID ARTHRITIS PAIN DESCRIPTORS IN UNPROMPTED FREE TEXT FROM THE INTERNET AND THE MacGill PAIN QUESTIONNAIRE. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 48). WILEY. 2021 Tiller, G., Renton, W., Munro, J., Whittle, S., Avery, J., Johnston, R., & Buchbinder, R. (2021). APRG MEMBER SURVEY TO IDENTIFY PRIORITY QUESTIONS FOR A LIVING GUIDELINE FOR THE PHARMACOLOGICAL MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 36). WILEY. 2020 Jimenez, D. F., Duron, G., Duarte-Garcia, A., Sufka, P., Whittle, S., Robinson, P., . . . Putman, M. (2020). A Systematic Review to Quantify the Extent of Pharmaceutical Company Involvement in Rheumatology Consensus-Based Recommendations. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 4 pages). ELECTR NETWORK: WILEY. 2020 Kwiatek, R., Crouch, B., True, B., Whittle, S., Walls, A., & Sherwood, V. (2020). NEUROINFLAMMATION IN FIBROMYALGIA ASSESSED BY PROTON MAGNETIC RESONANCE SPECTROSCOPY - A PILOT STUDY. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 48-49). WILEY. 2020 Davis, C., Ruediger, C., Dyer, K., Lester, S., Graf, S., Kroon, F. P. B., . . . Hill, C. (2020). COLCHICINE IS NOT EFFECTIVE FOR REDUCING OSTEOARTHRITIC HAND PAIN COMPARED TO PLACEBO: A RANDOMISED, PLACEBO-CONTROLLED TRIAL (COLAH). In ANNALS OF THE RHEUMATIC DISEASES Vol. 79 (pp. 793-794). ELECTR NETWORK: BMJ PUBLISHING GROUP.
DOI WoS12020 Dartnell, J., Elliott, J., Buchbinder, R., Hill, C., Barrett, C., Marine, F., . . . de Wever, J. (2020). DEVELOPING A COLLABORATIVE NATIONAL PROGRAM TO OPTIMISE USE OF BDMARDS. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 40-41). WILEY. 2020 Whittle, S., & Buchbinder, R. (2020). DURABILITY OF RHEUMATOLOGY GUIDELINE RECOMMENDATIONS: AN ANALYSIS OF UPDATED EULAR GUIDELINES 2005-2019. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 41). WILEY. 2020 Whittle, S., Thomas, M., Kamso, M. M., Pardo, J. P., Buchbinder, R., & Hazlewood, G. (2020). A LIVING NETWORK META-ANALYSIS OF TREATMENTS FOR RHEUMATOID ARTHRITIS: NOVELTY AT THE FRONTIER OF LIVING EVIDENCE. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 39). WILEY. 2019 Sharma, C., Whittle, S., Haghighi, P. D., Burstein, F., Sa'adon, R., & Keen, H. (2019). Mining Social Media Data to Investigate Patient Perceptions Regarding DMARD Pharmacotherapy for Rheumatoid Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 71 (pp. 2 pages). GA, Atlanta: WILEY. 2018 Calderon, L., Whittle, S., Hill, C., Sayad, J., Wells, G., & Milman, N. (2018). Methotrexate for Polymyalgia Rheumatica. In JOURNAL OF RHEUMATOLOGY Vol. 45 (pp. 1025-1026). Vancouver, CANADA: J RHEUMATOL PUBL CO. 2018 Leonardo, N., Lester, S., Graham, M., Whittle, S., Rowett, D., Buchbinder, R., & Hill, C. (2018). Attitudes and Beliefs Regarding Methotrexate in Patients with Rheumatoid Arthritis: Results from Australian Rheumatology Association Database. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 2 pages). IL, Chicago: WILEY.
WoS12013 Merriman, T., Phipps-Green, A., Black, M., Cadzow, M., Merriman, M., Topless, R., . . . Batt, C. (2013). SUGAR-SWEETENED BEVERAGE CONSUMPTION: A RISK FACTOR FOR PREVALENT GOUT THAT INTERACTS WITH SLC2A9 GENOTYPE IN A NON-ADDITIVE FASHION. In INTERNAL MEDICINE JOURNAL Vol. 43 (pp. 2). WILEY-BLACKWELL. 2003 Whittle, S., Lester, S. E., Downie-Doyle, S., Pile, K. D., & Rischmueller, M. (2003). Estrogen receptor alpha IVS1-401 (T/C) polymorphism in primary Sjogren's syndrome.. In ARTHRITIS AND RHEUMATISM Vol. 48 (pp. S567). ORLANDO, FLORIDA: WILEY-LISS. -
Conference Items
Year Citation 2023 Rushworth, L., Williams, P., Johnston, K., & Williams, M. (2023). Oral Presentation: Experience, Impacts and Influences on breathlessness amongst people receiving care in the intensive care unit (ICU): A Qualitative Interview Study.. Poster session presented at the meeting of Conference Abstract Booklet. Brisbane. 2021 Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Rowett, D., Black, R., . . . Hill, C. (2021). ATTITUDES OF AUSTRALIANS WITH INFLAMMATORY ARTHRITIS TO BIOLOGIC THERAPY AND BIOSIMILARS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 Venter, G., Tieu, J., Black, R., Lester, S., Leonardo, N., Whittle, S. L., . . . Hill, C. L. (2020). PERSPECTIVES OF GLUCOCORTICOID USE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 Davis, C., Ruediger, C., Dyer, K., Lester, S., Graf, S., Kroon, F., . . . Hill, C. (2020). COLCHICINE IS NOT EFFECTIVE FOR REDUCING OSTEOARTHRITIC HAND PAIN COMPARED TO PLACEBO: A RANDOMISED, PLACEBO-CONTROLLED TRIAL (COLAH). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 Whittle, S., Hill, C., & Buchbinder, R. (2020). ARA MEMBER SURVEY TO IDENTIFY PRIORITY QUESTIONS FOR A LIVING GUIDELINE FOR THE PHARMACOLOGICAL MANAGEMENT OF RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
WoS22020 Khoo, T., Hill, C., & Whittle, S. (2020). MEDICATION USE AND COMORBIDITIES OF PATIENTS WITH FIBROMYALGIA IN A HOSPITAL OUTPATIENT CLINIC. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 Lalor, A. F., Brooker, J. E., Rozbroj, T., Whittle, S., Hill, C., Rowett, D., . . . Buchbinder, R. (2020). CLINICIAN PERSPECTIVES FACTORS INFLUENCING PRESCRIBING AND USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN INFLAMMATORY RHEUMATIC DISORDERS FROM THE PERSPECTIVES OF CLINICIANS: A QUALITATIVE EVIDENCE SYNTHESIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2020 Lee, C., Thomas, M., Whittle, S., Buchbinder, R., Kamso, M., Pardo, J., & Hazlewood, G. (2020). Development and Pilot of Novel Process Using Machine Learning and Crowd-Sourcing to Conduct a Living Systematic Review of Rheumatoid Arthritis Drug Therapy. Poster session presented at the meeting of JOURNAL OF RHEUMATOLOGY. Victoria, CANADA: J RHEUMATOL PUBL CO. 2019 Calderon, L., Milman, N., Hill, C., Whittle, S., Sayad, J., Wells, G., & Pardo, J. (2019). Methotrexate for Giant Cell Arteritis. Poster session presented at the meeting of JOURNAL OF RHEUMATOLOGY. Montreal, CANADA: J RHEUMATOL PUBL CO. 2018 Leonardo, N., Lester, S., Graham, M., Whittle, S., Rowett, D., Buchbinder, R., & Hill, C. (2018). ATTITUDES OF RHEUMATOID ARTHRITIS PATIENTS TO METHOTREXATE. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2018 Chan, F., Lester, S., Whittle, S., & Hill, C. (2018). THE UTILITY OF ESR, CRP AND PLATELETS IN THE DIAGNOSIS OF GCA: A SOUTH AUSTRALIAN STATEWIDE ANALYSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2017 Whittle, S., Menz, F., Lester, S., Proudman, S., & Hill, C. (2017). THE DAS28-P INDEX AS A PREDICTOR OF POOR SUBJECTIVE RESPONSE TO DMARD THERAPY IN EARLY RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
WoS12017 Black, R., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., March, L., . . . Hill, C. (2017). FACTORS ASSOCIATED WITH ORAL GLUCOCORTICOID USE IN PATIENTS WITH RHEUMATOID ARTHRITIS ENROLLED IN THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2017 Pisaniello, H., Lester, S., Gonzalez-Chica, D., Longo, M., Sharplin, G., Dal Grande, E., . . . Hill, C. (2017). PREVALENCE AND PREDICTORS OF GOUT AND ALLOPURINOL USE, AND THEIR ASSOCIATION WITH RISK PERCEPTION: RESULTS FROM A SOUTH AUSTRALIAN POPULATION-BASED STUDY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
WoS12015 Ting, K., Whittle, S., & Hill, C. (2015). QUALITY OF REPORTING OF INTERVENTIONAL ANIMAL STUDIES IN RHEUMATOLOGY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2015 Haghighi, P. D., Kang, Y. -B., Tuan, H., Buchbinder, R., Burstein, F., & Whittle, S. (2015). Investigation of Environmental Associations of Fibromyalgia Pain Using Twitter Content Analysis. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Francisco: WILEY. 2013 Bourne, A., Whittle, S., Richards, B., Maher, C., & Buchbinder, R. (2013). MUSCULOSKELETAL CLINICAL TRIALS IN AUSTRALIA: WHAT TRIALS ARE BEING PERFORMED, WHO IS FUNDING THEM AND WHERE ARE THEY BEING PUBLISHED?. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2011 Richards, B., Whittle, S., & Buchbinder, R. (2011). THE EFFICACY AND SAFETY OF MUSCLE RELAXANTS IN INFLAMMATORY ARTHRITIS: A COCHRANE SYSTEMATIC LITERATURE REVIEW. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2011 Richards, B., Whittle, S., & Buchbinder, R. (2011). THE EFFICACY AND SAFETY OF NEUROMODULATORS IN INFLAMMATORY ARTHRITIS: A COCHRANE SYSTEMATIC REVIEW. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2011 Richards, B., Whittle, S., & Buchbinder, R. (2011). THE EFFICACY AND SAFETY OF ANTI-DEPRESSANTS IN INFLAMMATORY ARTHRITIS: A COCHRANE SYSTEMATIC REVIEW. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2011 Whittle, S., Richards, B., & Buchbinder, R. (2011). THE EFFICACY AND SAFETY OF OPIOIDS IN RHEUMATOID ARTHRITIS: A COCHRANE SYSTEMATIC REVIEW. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
-
Board Memberships
Date Role Board name Institution name Country 2016 - 2018 Treasurer Australian Rheumatology Association Australian Rheumatology Association Australia
Connect With Me
External Profiles
